<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00901394</url>
  </required_header>
  <id_info>
    <org_study_id>09-0074</org_study_id>
    <nct_id>NCT00901394</nct_id>
  </id_info>
  <brief_title>Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia</brief_title>
  <acronym>Mini-VINO</acronym>
  <official_title>Influence of Preoperative Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foundation for Anesthesia Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to find out if giving intravenous B-vitamins before general
      anesthesia with nitrous oxide prevents the increase in homocysteine, a metabolite that has
      been linked to cardiovascular complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized into the following arms:

        -  Arm A: patients will receive N2O (60% N2O/40% O2) in an open-label fashion during
           surgery and vitamin supplementation (vitamin B12, 1 mg, and folate, 5 mg) before
           surgery.

        -  Arm B: patients will receive N2O 60% N2O/40% O2) in an open-label fashion during surgery
           and placebo before and after surgery.

        -  Arm C: patients will not receive N2O, vitamin supplementation, or placebo during/before
           surgery. Patients in this arm will not be randomized.

      Patients will have blood drawn (total of 1-2 teaspoons over 3 days). We will take these
      samples before their surgery, when their surgery is completed, and 24, 48, and 72 hours after
      surgery. We will be checking their troponin I and troponin T, homocysteine, Vitamin B12, and
      folate levels. We will also take a blood sample to determine their MTHFR genotype and perform
      a 12-lead EKG. Before and after surgery for patients in Arm A or B, will receive either
      vitamin B12 (1 mg) and folic acid (5 mg) (or placebo) added to their IV infusion. We also
      plan to use a non-invasive test known as a nerve conduction study to measure the function of
      their nerve system. Briefly, 2 small electrodes are attached to their skin over a nerve and,
      like an EKG, faint electrical pulses are generated and recorded. A typical nerve conduction
      measurement lasts about 10 minutes.

      After the patients surgery we will do genetic testing of MTHFR genotype.

      All study samples have been collected. We would like to run a NT-ProBNP biomarker test on the
      samples.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative plasma total homocysteine concentrations (tHcy)</measure>
    <time_frame>Immediately postoperatively and on postoperative day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association of MTHFR 677C&gt;T genotype on tHcy increase</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">577</enrollment>
  <condition>Cardiovascular Abnormalities</condition>
  <arm_group>
    <arm_group_label>Treatment 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>B12-Folic acid, nitrous oxide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nitrous oxide (NO) and placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>oxygen nitrogen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>B12-Folic Acid, nitrous oxide</intervention_name>
    <description>IV vitamin B12 (cyanocobalamin) 1 mg, single administration over 30 min.
IV folic acid, 5 mg, single administration over 30 min.
Both diluted in 250 ml normal saline.</description>
    <arm_group_label>Treatment 1</arm_group_label>
    <other_name>b supplements</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitrous oxide (NO) and placebo</intervention_name>
    <description>60% nitrous oxide anesthesia plus saline</description>
    <arm_group_label>Treatment 1</arm_group_label>
    <arm_group_label>Treatment 2</arm_group_label>
    <other_name>nitrous oxide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Saline</description>
    <arm_group_label>Treatment 2</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
    <other_name>saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oxygen nitrogen</intervention_name>
    <description>60% air and oxygen mix.</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>air</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients scheduled for elective surgery with expected duration &gt; 2 hours

          -  Healthy patients undergoing moderate surgery where the use of N2O is unproblematic

        Exclusion Criteria:

          -  Contraindication against N2O (pneumothorax, mechanical bowel obstruction, middle ear
             occlusion, laparoscopic surgery, raised intracranial pressure)

          -  Patients requiring supplemental oxygen

          -  Urgent or emergent surgery

          -  Patients with vitamin B12 or folate deficiency or megaloblastic anemia

          -  Patients with seizure disorder (epilepsy)

          -  Allergy or hypersensitivity against IV cobalamin or folate

          -  Patients with Leber's disease (hereditary optic nerve atrophy)

          -  Patients taking supplemental vitamin B12 or folate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Nagele, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Nagele P, Zeugswetter B, Wiener C, Burger H, Hüpfl M, Mittlböck M, Födinger M. Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology. 2008 Jul;109(1):36-43. doi: 10.1097/ALN.0b013e318178820b.</citation>
    <PMID>18580170</PMID>
  </reference>
  <reference>
    <citation>Nagele P, Zeugswetter B, Eberle C, Hüpfl M, Mittlböck M, Födinger M. A common gene variant in methionine synthase reductase is not associated with peak homocysteine concentrations after nitrous oxide anesthesia. Pharmacogenet Genomics. 2009 May;19(5):325-9. doi: 10.1097/FPC.0b013e328328d54c.</citation>
    <PMID>19339913</PMID>
  </reference>
  <reference>
    <citation>Myles PS, Chan MT, Kaye DM, McIlroy DR, Lau CW, Symons JA, Chen S. Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology. 2008 Oct;109(4):657-63. doi: 10.1097/ALN.0b013e31818629db.</citation>
    <PMID>18813045</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2009</study_first_submitted>
  <study_first_submitted_qc>May 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2009</study_first_posted>
  <last_update_submitted>April 26, 2017</last_update_submitted>
  <last_update_submitted_qc>April 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nitrous oxide</keyword>
  <keyword>cobalamin</keyword>
  <keyword>homocysteine</keyword>
  <keyword>vitamin B12</keyword>
  <keyword>folate</keyword>
  <keyword>No specific diseases targeted</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Abnormalities</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Nitrous Oxide</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>April 23, 2018</submitted>
    <returned>May 21, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

